ACatechol, Inc.

ACatechol, Inc. is a MedTech startup that develops biomimetic surface engineering technologies inspired by nature. Founded in 2016, the company focuses on creating advanced coatings and adhesives, including gemini surface technology for long-lasting germicidal efficacy, non-invasive etch-less dental bonding and on-demand de-bonding solutions, and anti-biofouling coatings for medical catheters. Its technologies are designed to prevent the transmission of infectious diseases and address hospital-acquired infections through proprietary research into polymer material science and mussel-inspired adhesion. The company utilizes a multidisciplinary approach, blending academic research expertise with industry experience to commercialize its patented material science innovations.

These technologies offer significant clinical value by improving the durability and functionality of medical devices. The company has demonstrated the efficacy of its work through various research grants, including funding from the National Science Foundation and the National Institutes of Health. ACatechol has successfully transitioned some of its dental-related intellectual property through a licensing agreement with Danaher Corporation, which was later acquired by Envista Holdings. Currently, the company continues to advance its anti-infective catheter technology and seeks strategic partnerships to address global infection challenges in the healthcare sector.